source
- Experts discuss AI applications and challenges in regulatory conformity assessmentsAt a recent RAPS AI in Regulatory Conference in Barcelona, a panel of experts examined how artificial intelligence is being adopted in conformity assessment processes. Participants noted that noti…
- Aclaris Therapeutics’ bosakitug fails Phase 2 eczema trial, TSLP program droppedAclaris Therapeutics announced that its experimental antibody bosakitug (ATI-045) did not meet the primary endpoint in a Phase 2 study for moderate-to-severe atopic dermatitis. The double‑blind Ad…